Analystreport

Takeda Pharmaceutical Company Limited (NYSE: TAK) was upgraded by analysts at Cowen Inc from a "market perform" rating to an "outperform" rating.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)